LETTER
Concise Formal Synthesis of Unnatural (+)-Aphanorphine
163
(3) Shiotani, S.; Kometani, T.; Mitsuhashi, K.; Nozawa, T.;
Kurobe, A.; Fitsukaichi, O. J. Med. Chem. 1976, 19, 803.
(4) Palmer, D. C.; Strauss, M. J. Chem. Rev. 1977, 77, 1.
(5) (a) Coppola, G. M.; Schuster, H. F. Asymmetric Synthesis–
Construction of Chiral Molecules Using Amino Acids; John
Wiley & Sons: New York, 1987. (b) Hanessian, S. Total
Synthesis of Natural Products: The ‘Chiron’ Approach;
Pergamon: Oxford, 1983. (c) Ho, T.-L. Enantioselective
Synthesis: Natural Products from Chiral Terpenes; John
Wiley & Sons: New York, 1992.
(6) (a) Croce, P. D.; Rosa, C. L. Tetrahedron: Asymmetry 2002,
13, 197. (b) Portoghese, P. S.; Turcotte, J. G. Tetrahedron
1971, 27, 961.
(7) Williams, J. M.; Jobson, R. B.; Yasuda, N.; Marchesini, G.;
Dolling, U.-H.; Grabowski, E. J. J. Tetrahedron Lett. 1995,
36, 5461.
(12) 11: colorless oil; [a]28D +76.2 (c = 1.53, CHCl3). 1H NMR
(300 MHz, CDCl3): d = 1.48 (s, 2 H), 1.59 (s, 1 H), 1.90–2.10
(m, 2 H), 2.81 (s, 0.67 H), 2.98 (dd, J = 2.4, 17.1 Hz, 0.67
H), 3.30–3.54 (m, 2.66 H), 3.76 (s, 2 H), 3.80 (s, 1 H), 4.32–
4.37 (m, 0.33 H), 4.85–4.91 (m, 0.67 H), 6.70–6.80 (m, 1.65
H), 6.86 (d, J = 2.4 Hz, 0.35 H), 6.97 (d, J = 8.4 Hz, 0.35 H),
7.07 (d, J = 8.4 Hz, 0.65 H), 7.30–7.37 (m, 3.25 H), 7.41–
7.48 (m, 1.75 H). 13C NMR (75 MHz, CDCl3): d = 20.6, 20.8,
34.8, 37.3, 40.0, 41.0, 41.9, 42.2, 54.7, 54.9, 55.0, 56.4, 61.5,
64.1, 109.4, 109.5, 111.4, 111.5, 124.0, 125.3, 126.1, 126.5,
127.8, 128.1, 129.1, 129.2, 129.9, 130.2, 136.7, 137.2,
144.7, 145.6, 157.5, 157.9, 168.7, 169.8. MS (ESI): m/z =
308 (100) [M + H], 330 (6) [M + Na], 362 (19) [M + MeOH
+ Na]. HRMS (EI): m/z calcd for C20H21NO2: 307.1572;
found: 307.1570.
(13) Albaugh, P. A.; Marshall, L.; Gregory, J.; White, G.;
Hutchison, A.; Ross, P. C.; Gallagher, D. W.; Tallman, J. F.;
Crago, M.; Cassella, J. V. J. Med. Chem. 2002, 45, 5043.
(8) 8: colorless solid; mp 70–72 °C; [a]26D +95.7 (c = 0.91,
CHCl3). 1H NMR (300 MHz, CDCl3): d = 1.70–2.20 (m, 2
H), 2.55–3.05 (m, 1.5 H), 3.08–3.24 (m, 1.5 H), 3.50–3.60
(m, 1 H), 3.78 (s, 3 H), 4.00–4.30 (m, 1 H), 4.40–4.60 (m, 1
H), 6.55–6.70 (m, 1 H), 6.87 (d, J = 8.1 Hz, 1.5 H), 7.20 (d,
J = 7.8 Hz, 1.5 H), 7.35–7.50 (m, 5 H). 13C NMR (75 MHz
CDCl3): d = 37.0, 37.8, 55.1, 57.0, 57.6, 69.2, 113.6, 126.2,
127.1, 128.1, 130.1, 130.6, 136.4, 158.0, 170.0. MS (ESI):
m/z = 312 (100) [M + H], 333 (73) [M + Na – H], 366 (15)
[M + MeOH + Na], 645 (21) [2 × M + Na]. HRMS (EI):
m/z calcd for C19H21NO3: 311.1521; found: 311.1518.
(9) Huffman, J. W.; Yu, S. Bioorg. Med. Chem. 1998, 6, 2281.
(10) Mäkelä, T.; Matikainen, J.; Wähälä, K.; Hase, T.
Tetrahedron 2000, 56, 1873.
(14) (–)-Aphanorphine methyl ether 12: colorless oil; [a]28
–
D
10.38 (c = 1.36, CHCl3). 1H NMR (300 MHz, CDCl3): d =
1.46 (s, 3 H, CH3), 1.83 (d, J = 11.1 Hz, 1 H, 0.5 × CH2), 2.01
(dd, J = 6.0, 11.1 Hz, 1 H, 0.5 × CH2), 2.46 (s, 3 H, NCH3),
2.74 (d, J = 6.0 Hz, 1 H, 0.5 × CH2), 2.81 (s, 1 H, 0.5 × CH2),
2.84 (s, 1 H, 0.5 × CH2), 3.02 (d, J = 16.8 Hz, 1 H, 0.5 ×
CH2), 3.37–3.40 (m, 1 H, NCH), 3.75 (s, 3 H, OCH3), 6.67
(dd, J = 2.1, 8.4 Hz, 1 H, CH), 6.77 (s, 1 H, CH), 7.00 (d,
J = 8.4 Hz, 1 H, CH). 13C NMR (75 MHz, CDCl3): d = 21.2,
35.3, 41.3, 41.4, 42.9, 54.9, 61.1, 71.0, 109.1, 110.8, 125.6,
129.9, 147.6, 157.5. MS (EI): m/z = 218 (18) [M + H], 217
(48) [M], 202 (100), 159 (64), 144 (28), 115 (38). HRMS
(EI): m/z calcd for C14H19NO: 217.1467; found: 217.1460.
(11) Barton, D. H. R.; Bielska, M. T.; Cardoso, J. M.; Cussans, N.
J.; Ley, S. V. J. Chem. Soc., Perkin Trans. 1 1981, 1840.
Synlett 2007, No. 1, 161–163 © Thieme Stuttgart · New York